Michael Samarkos
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Antifungal resistance and susceptibility
- SARS-CoV-2 and COVID-19 Research
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- COVID-19 Clinical Research Studies 14
- Hematology 11
- Co-authors
- Panagiotis Fanourgiakis (7 shared papers)Eleni Kakalou (1 shared paper)Athanassios Skoutelis (1 shared paper)George Vaiopoulos (9 shared papers)Haralampos Μ. Moutsopoulos (2 shared papers)Helen J Gogas (7 shared papers)Mina Psichοgiou (8 shared papers)Maria G. Tektonidou (1 shared paper)
- Journals
- Antibiotics (5 papers)Seminars in Arthritis and Rheumatism (3 papers)Clinical Microbiology and Infection (3 papers)International Journal of Antimicrobial Agents (3 papers)Open Forum Infectious Diseases (3 papers)
- Partner nations
- GreeceUnited StatesNetherlands
In The Last Decade
Michael Samarkos
94 papers receiving 2.7k citations
Michael Samarkos's Hit Papers
Peers
Comparison fields: 5 of 100
- Infectious Diseases 662
- Molecular Medicine 157
- Rheumatology 324
- Applied Microbiology and Biotechnology 46
- Surgery 501
Countries citing papers authored by Michael Samarkos
This map shows the geographic impact of Michael Samarkos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Samarkos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Samarkos more than expected).
Fields of papers citing papers by Michael Samarkos
This network shows the impact of papers produced by Michael Samarkos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Samarkos. The network helps show where Michael Samarkos may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Samarkos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Pyogenic Vertebral Osteomyelitis: A Systematic Review of Clinical Characteristics Hit paper breakdown → | 2008 | 475 |
| 2 | Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial Hit paper breakdown → | 2021 | 431 |
| 3 | 2007 | 186 | |
| 4 | 2021 | 138 | |
| 5 | 2022 | 111 | |
| 6 | Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study Hit paper breakdown → | 2023 | 106 |
| 7 | 2021 | 98 | |
| 8 | 2019 | 91 | |
| 9 | 2018 | 60 | |
| 10 | 1998 | 57 | |
| 11 | 2017 | 53 | |
| 12 | 2005 | 50 | |
| 13 | 2021 | 50 | |
| 14 | 2010 | 49 | |
| 15 | 2005 | 46 | |
| 16 | 2005 | 33 | |
| 17 | 2018 | 30 | |
| 18 | 2001 | 29 | |
| 19 | 2000 | 28 | |
| 20 | 2001 | 27 |
About Michael Samarkos
Michael Samarkos is a scholar working on Infectious Diseases, Hematology, Molecular Medicine, Rheumatology and Applied Microbiology and Biotechnology, having authored 99 papers that have together received 2.8k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (14 papers), Systemic Lupus Erythematosus Research (10 papers), Antibiotic Resistance in Bacteria (8 papers), Antibiotic Use and Resistance (6 papers), Complement system in diseases (5 papers), Vasculitis and related conditions (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and COVID-19 and healthcare impacts (3 papers). The work is most often cited by research in Infectious Diseases (662 citations), Molecular Medicine (157 citations), Rheumatology (324 citations), Applied Microbiology and Biotechnology (46 citations) and Surgery (501 citations). Michael Samarkos has collaborated with scholars based in Greece, United States and Netherlands. Frequent co-authors include Panagiotis Fanourgiakis, Eleni Kakalou, Athanassios Skoutelis, George Vaiopoulos, Haralampos Μ. Moutsopoulos, Helen J Gogas, Mina Psichοgiou, Maria G. Tektonidou, Kevin A. Davies and S. Loizou. Their work appears in journals such as Antibiotics, Seminars in Arthritis and Rheumatism, Clinical Microbiology and Infection, International Journal of Antimicrobial Agents and Open Forum Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.